Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Accelerate Diagnosti (AXDX)

Accelerate Diagnosti (AXDX)
1.1700 +0.0200 (+1.74%) 01/24/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Jan 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.0700
Day High
1.2000
Open 1.1300
Previous Close 1.1500 1.1500
Volume 73,700 73,700
Avg Vol 65,025 65,025
Stochastic %K 29.95% 29.95%
Weighted Alpha -36.60 -36.60
5-Day Change +0.0500 (+4.46%) +0.0500 (+4.46%)
52-Week Range 0.7300 - 2.0900 0.7300 - 2.0900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,301
  • Shares Outstanding, K 25,044
  • Annual Sales, $ 12,060 K
  • Annual Income, $ -61,620 K
  • EBIT $ -38 M
  • EBITDA $ -31 M
  • 60-Month Beta 0.59
  • Price/Sales 2.03
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 379.70% ( -204.05%)
  • Historical Volatility 75.88%
  • IV Percentile 82%
  • IV Rank 39.33%
  • IV High 890.29% on 02/06/24
  • IV Low 48.74% on 10/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 155
  • Open Int (30-Day) 155

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.50
  • Number of Estimates 1
  • High Estimate -0.50
  • Low Estimate -0.50
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +43.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9900 +18.18%
on 12/27/24
Period Open: 1.0700
1.3800 -15.22%
on 01/03/25
+0.1000 (+9.35%)
since 12/24/24
3-Month
0.9900 +18.18%
on 12/27/24
Period Open: 1.7700
2.0400 -42.65%
on 11/06/24
-0.6000 (-33.90%)
since 10/24/24
52-Week
0.7300 +60.27%
on 04/18/24
Period Open: 1.3000
2.0900 -44.02%
on 09/03/24
-0.1300 (-10.00%)
since 01/24/24

Most Recent Stories

More News
Insider Purchase: Director at $AXDX (AXDX) Buys 200,000 Shares

JOHN PATIENCE, a director at $AXDX ($AXDX), bought 200,000 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics: Q3 Earnings Snapshot

AXDX : 1.1700 (+1.74%)
US settles with billionaire Carl Icahn for using company to secure personal loans worth billions

Billionaire Carl Icahn and his company were charged by U.S. regulators with failing to disclose personal loans worth billions of dollars that were secured using securities of Icahn Enterprises as collateral...

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics: Q2 Earnings Snapshot

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics: Q3 Earnings Snapshot

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics: Q2 Earnings Snapshot

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023....

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p....

AXDX : 1.1700 (+1.74%)
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.1700 (+1.74%)

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

3rd Resistance Point 1.3533
2nd Resistance Point 1.2767
1st Resistance Point 1.2233
Last Price 1.1700
1st Support Level 1.0933
2nd Support Level 1.0167
3rd Support Level 0.9633

See More

52-Week High 2.0900
Fibonacci 61.8% 1.5705
Fibonacci 50% 1.4100
Fibonacci 38.2% 1.2495
Last Price 1.1700
52-Week Low 0.7300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar